Rodger Novak's Net Worth

Rodger Novak's net worth is estimated to be at least $53,193,717.23 as of 11/08/2024. CoreStreet's estimation of Rodger Novak's net worth is based on their sale of stock and current holding of stock.

Rodger Novak is President at Crispr Therapeutics AG. They have executed at least 25 trades of stock as per SEC Form 4 filings. Their most recent trade was for 25,000 units of CRSP stock on 06/30/2021. Their biggest sale was on 11/30/2020 when they sold 100,000 units of Crispr Therapeutics AG stock for $12,500,000.00. They typically trade 5 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $53,193,717.23
Most recent insider trade:
  • June 30, 2021

Rodger Novak's Insider Trading History

Crispr Therapeutics AGTitleAmountPriceTypeTotal Value
June 30, 2021
President25,000$165.00Sell$4,125,000.00
June 21, 2021
President25,000$128.62Sell$3,215,500.00
Nov. 30, 2020
President100,000$125.00Sell$12,500,000.00
Sept. 1, 2020
President25,000$92.62Sell$2,315,500.00
July 7, 2020
President25,000$90.00Sell$2,250,000.00
June 23, 2020
President50,000$75.00Sell$3,750,000.00
May 19, 2020
President50,000$65.00Sell$3,250,000.00
Nov. 19, 2019
President33,618$70.00Sell$2,353,260.00
July 10, 2019
President50,000$50.00Sell$2,500,000.00
June 10, 2019
President50,000$45.00Sell$2,250,000.00
March 4, 2019
President85,220$40.40Sell$3,442,888.00
March 1, 2019
President8,693$40.01Sell$347,806.93
Feb. 25, 2019
President14,780$40.00Sell$591,200.00
Jan. 8, 2019
President17,310$35.09Sell$607,407.90
May 17, 2018
President75,000$60.00Sell$4,500,000.00
Sept. 5, 2017
CEO18,470$20.76Sell$383,437.20
Aug. 30, 2017
CEO75,795$20.25Sell$1,534,848.75
June 22, 2017
CEO10,825$15.37Sell$166,380.25
June 21, 2017
CEO30,222$15.01Sell$453,632.22
June 9, 2017
CEO5,303$15.02Sell$79,651.06
May 30, 2017
CEO3,650$15.02Sell$54,823.00
May 17, 2017
CEO50,000$16.26Sell$813,000.00
May 5, 2017
CEO616$16.92Sell$10,422.72
May 4, 2017
CEO49,384$16.30Sell$804,959.20
April 20, 2017
CEO50,000$17.88Sell$894,000.00